empagliflozin vs semaglutide 2026 Update: is now an approved medication for cardiovascular diseases. It is recommended for the treatment of Type 2 diabetes and secondary prevention of cardiovascular complications in adults with established heart Ozempic outperforms another diabetes drug

Research found that patients prescribed tirzepatide who actively participated in Voys science-backed programme achieved an average weight loss of 22% after 11 months

Each pen is precisely dosed and tested for quality

Rubino, D

Refrigerate between 36 and 46 degrees Fahrenheit (2 to 8 degrees Celsius)

The benefits of dapagliflozin and empagliflozin were observed in the composite outcomes of CV death or hospitalization for HF across major subgroups, including those with and without diabetes, HF with reduced or preserved ejection fraction, New York Heart Association functional class, and the presence or absence of CKD [65,66]